Ovation Science Inc. (CSE:OVAT)
Canada · Delayed Price · Currency is CAD 0.0300
+0.0100 (50.00%)
Jul 30, 2026, 5:47 PM EST
Ovation Science Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.04 | 0.07 | 0 | 0.05 | 0.03 | 0.65 |
Cash & Short-Term Investments | 0.04 | 0.07 | 0 | 0.05 | 0.03 | 0.65 |
Cash Growth | 285.02% | 2082.73% | -93.22% | 69.02% | -95.54% | -57.90% |
Accounts Receivable | 0.01 | 0 | 0.03 | 0 | 0.05 | 0.08 |
Other Receivables | - | 0.01 | 0.01 | 0 | 0.01 | 0.02 |
Receivables | 0.01 | 0.01 | 0.03 | 0.01 | 0.06 | 0.09 |
Inventory | - | - | 0.03 | 0.02 | 0 | 0 |
Prepaid Expenses | - | - | - | 0 | 0.01 | 0.01 |
Other Current Assets | - | - | - | - | - | 0 |
Total Current Assets | 0.05 | 0.08 | 0.06 | 0.07 | 0.1 | 0.76 |
Property, Plant & Equipment | - | - | - | 0 | 0.01 | 0.01 |
Total Assets | 0.05 | 0.08 | 0.06 | 0.08 | 0.1 | 0.77 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.15 | 0.14 | 0.13 | 0.06 | 0.02 | 0.02 |
Accrued Expenses | 1.2 | 1.12 | 0.74 | 0.42 | 0.12 | 0.04 |
Short-Term Debt | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | - |
Current Portion of Long-Term Debt | 0.26 | 0.26 | 0.25 | 0.15 | - | - |
Other Current Liabilities | - | - | 0.02 | 0.06 | - | - |
Total Current Liabilities | 1.64 | 1.54 | 1.15 | 0.71 | 0.17 | 0.06 |
Long-Term Debt | - | - | - | 0.02 | 0.02 | - |
Total Liabilities | 1.64 | 1.54 | 1.15 | 0.73 | 0.19 | 0.06 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 4.59 | 4.59 | 4.52 | 4.46 | 4.28 | 4.28 |
Retained Earnings | -7.79 | -7.68 | -7.05 | -6.59 | -5.78 | -4.98 |
Comprehensive Income & Other | 1.61 | 1.63 | 1.43 | 1.48 | 1.42 | 1.41 |
Shareholders' Equity | -1.59 | -1.46 | -1.09 | -0.65 | -0.08 | 0.71 |
Total Liabilities & Equity | 0.05 | 0.08 | 0.06 | 0.08 | 0.1 | 0.77 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.29 | 0.28 | 0.27 | 0.19 | 0.04 | - |
Net Cash (Debt) | -0.25 | -0.21 | -0.27 | -0.14 | -0.01 | 0.65 |
Net Cash Growth | - | - | - | - | - | -57.90% |
Net Cash Per Share | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 | 0.02 |
Filing Date Shares Outstanding | 38.41 | 38.41 | 35.24 | 33.89 | 29.37 | 29.37 |
Total Common Shares Outstanding | 38.41 | 38.41 | 35.24 | 33.89 | 29.37 | 29.37 |
Working Capital | -1.59 | -1.46 | -1.09 | -0.64 | -0.07 | 0.69 |
Book Value Per Share | -0.04 | -0.04 | -0.03 | -0.02 | -0.00 | 0.02 |
Tangible Book Value | -1.59 | -1.46 | -1.09 | -0.65 | -0.08 | 0.71 |
Tangible Book Value Per Share | -0.04 | -0.04 | -0.03 | -0.02 | -0.00 | 0.02 |
Machinery | - | - | - | - | - | 0.03 |